Blog & News

CABO GIST

Sep 1, 2016 |

CABO GIST Agents: Cabozantinib Phase II Status  Completed Sponsor EORTC   Further information: https://clinicaltrials.gov/ct/show/NCT02216578 or http://www.eortc.org/research_field/clinical-detail/1317/   WHO is the trial for? Patients with metastatic GIST (histologically confirmed) and removed primary tumor Patients with progression during treatment of GIST (before or after surgery,…

Mitigate

Sep 1, 2016 |

The Mitigate Project Agents: A novel PET-CT tracer specifically developed to target cell surface receptors of GIST cells Phase I/IIa Status  Open, recruiting Sponsor Medical University Innsbruck, European Union Further information: www.mitigate-project.eu WHO is the trial for?   Patients with progressive disease…

STRASS Trial

Sep 1, 2016 |

Surgery With or Without Radiation Therapy in Treating Patients With Previously Untreated Nonmetastatic Retroperitoneal Soft Tissue Sarcoma (STRASS) Agents: Radiation therapy followed by surgery vs. surgery alone Phase III Status  Open, recruiting Sponsor European Organisation for Research and Treatment of Cancer –…

SPAEN Advocacy in Action Award 2021

Sep 1, 2016 |

SPAEN Advocacy in Action Award 2021 announced for best projects in sarcoma patients advocacy Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. We believe it is time to…

SPAEN Advocacy in Action Award 2018: The winners are… (2)

Sep 1, 2016 |

  Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. The projects that were entered for the “Sarcoma Advocacy in Action Award 2018” once again showed this impressively! All…

SPAEN Advocacy in Action Award 2019: The winners are…

Sep 1, 2016 |

  Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. The 12 projects that were entered for the “Sarcoma Advocacy in Action Award 2019” once again showed this impressively!…

Patient led PROMs must take centre stage in cancer research

Sep 1, 2016 |

by Roger Wilson, co-founder and honorary president of SPAEN and founder of Sarcoma UKResearch Involvement and Engagement, February 2018   Patient involvement in research is about adding value rather than commenting on technical quality. After 15 yearsas an involved patient in cancer…

Call to action: SPAEN Advocacy in Action Award 2019

Sep 1, 2016 |

SPAEN Advocacy in Action Award for best projects in sarcoma patients advocacy Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. We believe it is time to shout out…

SPAEN Advocacy in Action Award 2017: And the award goes to…

Sep 1, 2016 |

    Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. We decided that it is time to shout out about how important patient advocacy in sarcomas is –…

2018 SPAEN Annual Conference: 3-4 February 2018, Milan/Italy

Sep 1, 2016 |

  SPAEN Annual Conference combined with ESMO GIST/Sarcoma expert meeting in 2018 SPAEN is very excited that for the first time, the SPAEN Annual Conference 2018 will be held combined with a professional meeting. SPAEN and European Society of Medical Oncology (ESMO) have…